16.03.20
This is an updated version of the statement shared last week (13/3) regarding coronavirus (COV-19) containing new information.
Read more13.03.20
A summary of our current information and advice on the coronavirus outbreak.
Read more06.03.20
An open letter to the rare disease community updating on Scotland's position with regard to rare disease. The letter sets out detailed progress with regards to its the three priorities of the Rare Disease Strategic Oversight Group (RDSOG); coordination of care,raising awareness of rare disease amongst health professionals and research.
Read more05.03.20
Advice for patients / parents / guardians regarding Coronavirus (COVID-19)...
Read more04.03.20
Oxford, UK / IntraBio Inc. is pleased to announce that the Extension Phase for the IB1001-201 Clinical Trial has been accepted by the FDA (US Food and Drug Administration). The Extension Phase has also been previously approved by all European countries in which the trial is being conducted, including Germany, Slovakia, Spain, and the UK.
Read more